Tuberculosis and Respiratory Diseases

The Korean Academy of Tuberculosis and Respiratory Diseases (대한결핵및호흡기학회)
권호 표지
DOI QR코드

DOI QR Code

Respiratory Vaccination

호흡기 예방접종

  • Park, Sang-Won (Department of Internal Medicine, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul National University College of Medicine)
  • 박상원 (서울대학교 의과대학 내과학교실, 보라매병원 감염내과)
  • Received : 2010.12.23
  • Accepted : 2010.12.23
  • Published : 2011.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Vaccination in adults is recommended according to the age group and underlying diseases or risks of exposure. Patients with chronic diseases including chronic obstructive pulmonary diseases are susceptible to infectious diseases and related serious complications. They need risk-related vaccination along with age-related vaccination. Both influenza and pneumococcal vaccination are recommended in patients with chronic obstructive pulmonary diseases. They are additive if administered simultaneously. Pertussis vaccination is also needed in adolescents and adults. Although there is strong need for these vaccinations, the actual vaccination rate is low. Measures to effectively enhance the vaccination rate are needed.

Keywords

References

  1. Korean Society of Infectious Diseases. Vaccination for adult. Seoul, Korea: Goonja publication; 2007.
  2. Centers for Disease Control and Prevention (CDC). Recommended adult immunization schedule--United States, 2011. MMWR Morb Mortal Wkly Rep 2011;60:1-4.
  3. Ball P. Epidemiology and treatment of chronic bronchitis and its exacerbations. Chest 1995;108 Suppl 2:43S-52S. https://doi.org/10.1378/chest.108.2_Supplement.43S
  4. Sapey E, Stockley RA. COPD exacerbations. 2: aetiology. Thorax 2006;61:250-8. https://doi.org/10.1136/thx.2005.041822
  5. Neuzil KM, Reed GW, Mitchel EF Jr, Griffin MR. Influenza-associated morbidity and mortality in young and middle-aged women. JAMA 1999;281:901-7. https://doi.org/10.1001/jama.281.10.901
  6. Wilde JA, McMillan JA, Serwint J, Butta J, O'Riordan MA, Steinhoff MC. Effectiveness of influenza vaccine in health care professionals: a randomized trial. JAMA 1999;281:908-13. https://doi.org/10.1001/jama.281.10.908
  7. Nichol KL, Wuorenma J, von Sternberg T. Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. Arch Intern Med 1998;158:1769-76. https://doi.org/10.1001/archinte.158.16.1769
  8. Nichol KL, Baken L, Nelson A. Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease. Ann Intern Med 1999;130:397-403. https://doi.org/10.7326/0003-4819-130-5-199903020-00003
  9. Song JY, Cheong HJ, Hwang IS, Choi WS, Jo YM, Park DW, et al. Long-term immunogenicity of influenza vaccine among the elderly: risk factors for poor immune response and persistence. Vaccine 2010;28:3929-35. https://doi.org/10.1016/j.vaccine.2010.03.067
  10. Fiore AE, Uyeki TM, Broder K, Finelli L, Euler GL, Singleton JA, et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 2010;59:1-62.
  11. Nichol KL, Baken L, Wuorenma J, Nelson A. The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic lung disease. Arch Intern Med 1999;159:2437-42. https://doi.org/10.1001/archinte.159.20.2437
  12. Nichol KL. The additive benefits of influenza and pneumococcal vaccinations during influenza seasons among elderly persons with chronic lung disease. Vaccine 1999;17 Suppl 1:S91-3. https://doi.org/10.1016/S0264-410X(99)00114-0
  13. Schenkein JG, Nahm MH, Dransfield MT. Pneumococcal vaccination for patients with COPD: current practice and future directions. Chest 2008;133:767-74. https://doi.org/10.1378/chest.07-0996
  14. Jackson LA, Neuzil KM, Yu O, Benson P, Barlow WE, Adams AL, et al. Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med 2003;348:1747-55. https://doi.org/10.1056/NEJMoa022678
  15. Schenkein JG, Nahm MH, Dransfield MT. Pneumococcal vaccination for patients with COPD: current practice and future directions. Chest 2008;133:767-74. https://doi.org/10.1378/chest.07-0996
  16. Furumoto A, Ohkusa Y, Chen M, Kawakami K, Masaki H, Sueyasu Y, et al. Additive effect of pneumococcal vaccine and influenza vaccine on acute exacerbation in patients with chronic lung disease. Vaccine 2008;26:4284-9. https://doi.org/10.1016/j.vaccine.2008.05.037
  17. Park WB, Park SW, Kim HB, Kim EC, Oh M, Choe KW. Pertussis in adults with persistent cough in South Korea. Eur J Clin Microbiol Infect Dis 2005;24:156-8. https://doi.org/10.1007/s10096-005-1277-y